Solit, D. B., Osman, I., Polsky, D., Panageas, K. S., Daud, A., Goydos, J. S., . . . Chapman, P. B. (2008). Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma.
Citación estilo ChicagoSolit, David B., et al. Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma. 2008.
Cita MLASolit, David B., et al. Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma. 2008.
Precaución: Estas citas no son 100% exactas.